Silicon Valley Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5
Closed -$2.03K 339
2025
Q2
$2.03K Buy
+5
New +$2.09K ﹤0.01% 279
2025
Q1
Sell
-20
Closed -$10.4K 315
2024
Q4
$10.4K Hold
20
﹤0.01% 251
2024
Q3
$12.4K Hold
20
﹤0.01% 232
2024
Q2
$11.1K Hold
20
﹤0.01% 231
2024
Q1
$11.6K Hold
20
﹤0.01% 219
2023
Q4
$10.6K Hold
20
﹤0.01% 250
2023
Q3
$10.1K Hold
20
﹤0.01% 194
2023
Q2
$10.4K Sell
20
-31
-61% -$16.7K ﹤0.01% 196
2023
Q1
$29.4K Buy
+51
New +$28.7K 0.01% 114

Other funds holding TMO

Silicon Valley Capital Partners's TMO Position: Q3 2025 in Review

Silicon Valley Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 5 shares — an estimated $2.03K sold.

Silicon Valley Capital Partners first reported a position in TMO in Q1 2023 and held it in 9 quarters. The position peaked at $29.4K in Q1 2023. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Silicon Valley Capital Partners reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Silicon Valley Capital Partners sold 5 Thermo Fisher Scientific shares in Q3 2025, an estimated $2.03K.
  • Silicon Valley Capital Partners first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 9 quarters.
  • Silicon Valley Capital Partners's Thermo Fisher Scientific position peaked at $29.4K in Q1 2023.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Silicon Valley Capital Partners's 13F filing for Q3 2025, filed 17 Nov 2025.